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ABSTRACT
Objective. To determine if experienced 
health care providers (HCPs) can rec-
ognise patients with fibromyalgia (FM) 
based on a limited set of personality 
items, exploring the existence of a FM 
personality.
Methods. From the 240-item NEO-PI-
R personality questionnaire, 8 HCPs 
from two different countries each se-
lected 20 items they considered most 
discriminative of FM personality. Then, 
evaluating the scores on these items of 
129 female patients with FM and 127 
female controls, each HCP rated the 
probability of FM for each individual 
on a 0–10 scale. Personality charac-
teristics (domains and facets) of se-
lected items were determined. Scores 
of patients with FM and controls on the 
eight 20-item sets, and HCPs’ estimates 
of each individual’s probability of FM 
were analysed for their discriminative 
value.
Results. The eight 20-item sets dis-
criminated for FM, with areas under 
the receiver operating characteristic 
curve ranging from 0.71–0.81. The es-
timated probabilities for FM showed, 
in general, percentages of correct clas-
sifications above 50%, with rising cor-
rect percentages for higher estimated 
probabilities. The most often chosen 
and discriminatory items were pre-
dominantly of the domain neuroticism 
(all with higher scores in FM), followed 
by some items of the facet trust (lower 
scores in FM). 
Conclusion. HCPs can, based on a 
limited set of items from a personal-
ity questionnaire, distinguish patients 
with FM from controls with a statisti-
cally significant probability. The HCPs’ 
expectation that personality in FM pa-
tients is associated with higher levels 
for aspects of neuroticism (proneness 
to psychological distress) and lower 
scores for aspects of trust, proved to be 
correct.
Introduction
Fibromyalgia (FM) is a common con-
dition characterised by otherwise un-
explained widespread musculoskeletal 
pain and tenderness (1), commonly 
associated with fatigue, poor quality 
sleep, cognitive disturbance and emo-
tional distress (1-3). It affects 2–5% of 
the population within Western societies 
(4, 5), more women than men and has 
a major negative impact upon quality 
of life, resulting in high societal costs 
from medical, psychological and finan-
cial points of view (2, 6). The condi-
tion is poorly understood and difficult 
to manage (7). There are overlapping 
features between FM, chronic fatigue 
syndrome and mood spectrum disor-
ders, suggesting common underlying 
mechanisms (8).
Health care providers (HCPs) typically 
associate FM with certain personality 
traits, leading to descriptions such as 
demanding (9, 10), perfectionistic, am-
bitious, active, illness focused, medi-
calising (10), and difficult to deal with 
(11). One paper reflects this in its title: 
“helping your patient while maintain-
ing your sanity” (12). In a study, over 
70% of rheumatologists considered 
that they should not be the main HCP 
for these patients, on the basis that FM 
could better be considered a psychoso-
matic disorder (13).
However, research into the association 
of personality with FM has provided 
inconclusive results. Most studies in-
dicate that FM is associated with high 
neuroticism (14, 15), or high levels of 
correlates of this trait, such as harm 
avoidance (16, 17) or alexithymia (18). 
However, some studies find no signifi-
cant difference for neuroticism or nega-
tive affect regulation (9, 19, 20), but 
lower levels of extraversion and posi-
tive affect regulation (19). A compre-
hensive review suggested that, although 
many patients with FM show personal-
ity characteristics associated with in-
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adequate psychological responses to 
stressful situations, such as catastro-
phising or applying poor coping tech-
niques, no personality profile is specific 
to FM (21).
Personality is generally seen as a rela-
tively stable assembly of behavioural, 
cognitive and affective patterns of indi-
vidual response (10), which determine 
how an individual reacts and adapts to 
external stimuli and circumstances. Al-
though no single instrument can fully 
capture the complexity of personality, 
there is general consensus that person-
ality is structured by 5 main domains 
(the so-called “big five”) (22). These 
are neuroticism (anxious, easily upset 
vs. calm, emotionally stable), extra-
version (energetic, enthusiastic vs. re-
served, quiet), openness to experience 
(open to new experiences, complex vs. 
conventional, uncreative), agreeable-
ness (sympathetic, warm vs. critical, 
quarrelsome) and conscientiousness 
(dependable, self-disciplined vs. disor-
ganised, careless) (23).
Aims of the study
The primary aim was to investigate 
whether and to what extent experienced 
HCPs can recognise FM patients among 
a sample of FM patients and healthy 
controls, based solely on a limited set 
of personality inventory items, explor-
ing the existence of a FM personality.
Secondary aims were: a) to investigate 
which of a limited set of personality 
items can discriminate individuals with 
and without FM and to which personal-
ity characteristics (domains and facets) 
these items belong; b) to assess agree-
ment between HCPs upon the most dis-
criminating personality questionnaire 
items; c) to assess agreement between 
HCPs upon their ratings of estimated 
probability of FM for individual per-
sons. We had no intentions of establish-
ing or implying causality in this study.
Material and methods
Population sample
Participants were recruited in two pri-
vate rheumatology and gynaecology 
outpatient clinics in Coimbra, Portu-
gal, sharing similar socio-demographic 
settings (mainly low to middle class 
females). Consecutive female patients 
satisfying the 1990 ACR criteria for FM 
(1), (basically, a history of unexplained 
chronic generalised pain and tender 
points at physical examination), n=129, 
were invited to take part in this study 
at the end of their first visit. They were 
asked to fill out the personality ques-
tionnaire, before they were given infor-
mation on their FM. Controls, n=127, 
were recruited among females attend-
ing a routine gynaecological observa-
tion. The only exclusion criteria were, 
1) for FM patients, presence of any 
other chronic painful condition, and 
for controls, chronic pain of any origin, 
by self-report; 2) inability to read and 
understand the questionnaires and 3) 
refusal to sign informed consent. Their 
professions were classified into white 
or blue collar avocations or retired/no 
profession.
Health care providers
Four rheumatologists and four psychol-
ogists experienced in the management 
of FM patients, two from Portugal and 
two from the Netherlands in each pro-
fession, accepted to participate. There 
were 2 women and 6 men, their mean 
age was 51 (range 36–62) years, and 
their mean years of professional expe-
rience with FM was 19 (range 11–25). 
A ninth researcher, JWGJ, kept the da-
tabase, collected the HCPs’ responses 
and performed statistical analyses, 
while blinded to the group classifica-
tion of the participants and the actual 
description of each NEO-PI-R item. 
This blinding was only broken in the 
writing phase of this manuscript, after 
data analyses had been completed.
Questionnaire
Participants were asked to fill out with-
out assistance the validated Portuguese 
version of the NEO Personality Inven-
tory – Revised (NEO-PI-R) question-
naire, (24-26) and to send it through 
the mail to the principal investigator 
(JAPS), prior to the subsequent out-
patient consultation. The attached in-
formation explained that the objective 
was to investigate whether different 
rheumatic conditions are associated 
with different psychological profiles, 
and that the data were collected for 
research only, fully independent of the 
subsequent consultation. No hints were 
given regarding character traits poten-
tially associated with FM.
The NEO-PI-R consists of 240 items, 
each presenting a statement about one-
self, to be scored from 0 (totally disa-
gree) to 4 (totally agree). The NEO 
PI-R is a well validated, transculturally 
generalisable measure of the five ma-
jor domains of personality (24, 25, 27). 
Each domain consists of 6 facets and 
each facet consists of 8 items; for facet 
and domain scores, corresponding item 
scores are summed, after recoding for 
negative formulated items (28), see 
Supplementary file S1 and Table S2.
Procedures
The HCPs were asked to complete 
tasks in two successive phases. 
Phase 1. Selection of potentially dis-
criminating NEO-PI-R items.
HCPs received a numbered list with 
actual description of all the 240 NEO-
PI-R items (28), in their validated na-
tive language versions (26, 27, 29), and 
were given the following assignment: 
“Please make your best effort to select, 
from these 240 items of NEO-PI-R a 
set of up to 20 items you feel as capa-
ble of discriminating between FM pa-
tients and controls. Please indicate, for 
each of the items you select, whether it 
would be scored higher or lower by FM 
patients as opposed to controls.” 
Phase 2. Estimation of the probability 
of having FM among individual par-
ticipants.
Each of the HCPs received the scores of 
participants on the 20 NEO-PI-R items 
they had selected in phase 1, for each 
HCP in a different random order of par-
ticipants. The scores were presented 
as filled out by participants, i.e. with-
out recalculation of scores on negative 
items. HCPs were asked to “attribute to 
each individual participant a probabil-
ity of her having FM, on a zero to 10 
scale: 0= surely not an FM patient to 
10= surely an FM patient, 5 represent-
ing absolute uncertainty. Please note 
that you are not being informed, at this 
phase, how many of the participants 
are FM patients and how many are 
controls. They are all female.” It was 
stressed that all HCPs were expected to 
do their best possible evaluation, irre-
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spective of their pre-existing opinion on 
the research questions and hypotheses. 
All HCPs (with exception of JAPS, 
who had recruited the participants) re-
mained blind as to the number of FM 
patients and controls. 
Ethics
The study was approved by Ethics 
Committee of the Portuguese Medi-
cal Board (Centre Section). All par-
ticipants signed an approved informed 
consent form before any study proce-
dures were undertaken.
Statistics
For the primary aim, to investigate 
whether and to what extent HCPs can 
recognise a specific FM personality, 
the scores on each individual set of 20 
items selected in phase 1 were analysed 
as independent variables in logistic re-
gression. This yielded for each HCP’s 
set an area under the receiver operating 
characteristic (AU ROC) curve with 
95% confidence interval.
In a 2x2 table, the number of NEO-
PI-R items selected in phase 1 as dis-
criminating between FM and controls 
and the number of not selected items 
were tabulated versus the number of 
NEO-PI-R items with and those with-
out statistically significantly different 
scores between FM patients and con-
trols. This 2x2 table was tested for sig-
nificance using Fisher’s exact test. Also 
the scores of NEO-PI-R items selected 
by ≥3 of the 8 HCPs in phase 1 were 
tested for differences between FM pa-
tients and controls. Testing item scores 
between FM patients and controls was 
performed with Mann-Whitney U-
tests. To test item scores corrected for 
covariates, analysis of covariance was 
applied.
For each probability score for FM ac-
quired during phase 2 (integers, range 
0-10), the numbers of participants hav-
ing been given that score were calcu-
lated, with the percentages correct clas-
sification. Correct classification was 
defined as a score ≥6 for FM and ≤4 for 
controls. For calculations of statistical 
significance of differences of propor-
tions from 0.5 (chance), exact (binomi-
nal) tests were used.
Between the 8 sets of 20 items cho-
sen and 220 items not chosen, agree-
ment analyses were performed, some 
of them chance-corrected (30). We 
chose to perform several agreement 
tests, because of the nature of this data 
with many not chosen items, yielding 
different agreement results and inter-
pretations. E.g., if we would have had 
2 HCPs, each selecting 20 out of 240 
items, and if 5 items would have been 
chosen by both, kappa would have 
been 0.18, which would be interpreted 
as slight agreement, but the percent-
age agreement would have been 0.88, 
which could be interpreted as almost 
perfect agreement. 
The agreement tests applied were Con-
ger’s kappa (generalised kappa), Gwet 
for chance adjusted first-order agree-
ment coefficient, Fleiss’ kappa (gen-
eralised Pi of Scott), Krippendorff’s 
alpha (agreement coefficient based on 
observed and expected disagreement), 
and the free-marginal kappa of Bren-
nan and Prediger (30).
To assess the agreement between 
the 8 HCPs upon the estimated prob-
ability (0 to 10, integers) of individual 
participants of having FM, the same 
agreement measures were calculated, 
but as weighted analyses. Custom 
weights were: no difference between 
integer scores: weight=1; 1 point dif-
ference: weight=0.7; 2 points differ-
ence: weight=0.4; 3 points difference: 
weight=0.2; ≥4 points difference: 
weight=0. 
Interpretation of agreement coeffi-
cients is according to Landis-Koch, re-
Table I. The number, age distribution and profession category of fibromyalgia and non-
fibromyalgia control subjects, all female*.
 Fibromyalgia subjects Control subjects
Number 129 127
Age, median (95% CI), years* 46 (42-48) 49 (47-51)*
Profession (n)  
White collar 82 80
Blue collar 25 23
Retired/no profession 22 24
*no statistically significant differences between groups, except for age, p=0.002.
Table II. Twenty item sets selected by each of the 8 health care providers (HCPs), with power to discriminate fibromyalgia*.
HCP Item numbers** of NEO Personality Inventory - Revised questionnaire  AU 95% CI p-value % correctly
  ROC AU ROC  predicted    
  curve curve
HCP A r1, 66, r71, 86, 91, 100, 101, 135, 160, 165, 167, r176, 191, 195, 200, 201, 207, 216, 230, r236 0.81 0.76-0.86 0.0000 75
HCP B r1, r11, 15, 21, 26, 42, r47, r61, r71, 91, r107, 120, 148, 161, r177, 179, 186, 191, 205, 221 0.74 0.67-0.79 0.0000 65
HCP C r6, 15, r26, 41, 55, r66, 80, 86, 87, 91, r130, r136, 146, 151, 161, r187, 191, r205, 220, r229 0.76 0.70-0.82 0.0000 68
HCP D 6, r10, r11, r12, 15, 26, 27, r43, r59, 91, 100, r116, r121, 161, 165, 194, 200, 216, 224, 225 0.74 0.67-0.79 0.0000 64
HCP E r1, 15, 42, 54, r56, 64, 79, r94, 104, 115, 120, 137, 140, 151, r177, r190, 191, 213, 222, 235 0.77 0.70-0.82 0.0000 68
HCP F 6, 15, 16, 26, 41, 64, 79, 86, 91, 101, 131, 136, 151, 160, 161, 186, 191, 216, 221, 224 0.80 0.74-0.84 0.0000 71
HCP G r1, 6, 41, r61, 64, 86, 91, r107, r121, 126, 137, 160, r190, 200, 216, 220, 222, 224, 225, r236 0.79 0.73-0.84 0.0000 73
HCP H 6, r11, r36, 42, r61, 70, r71, 90, 115, r121, 130, 131, r141, 160, 171, 186, 191, 197, 204, 225 0.71 0.64-0.77 0.0000 65
*results of binary logistic regression for each of the 20 item sets, dependent variable: fibromyalgia / non-fibromyalgia, independent variables: each 20-item 
set. AU ROC curve: area under the receiver operating characteristic curve; 95%CI: 95% confidence interval.
**The contents of items preceded by “r” are negatively associated with fibromyalgia according to each HCP.
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sulting in 6 classes of agreement: poor, 
slight, fair, moderate, substantial and 
almost perfect agreement, respectively 
(30, 31).
All tests were two-sided; p<0.05 was 
considered statistically significant; no 
correction for multiple testing was ap-
plied. For analyses, SPSS v. 22 (IBM, 
New York, USA), NCSS 9 Statisti-
cal Software (NCSS, LLC. Kaysville, 
Utah, USA), and AgreeStat 2015.4 
(Advanced Analytics, LLC, Maryland, 
USA) were used.
Results
Table I shows participants’ main char-
acteristics. The 8 sets of 20-items se-
lected by the HCPs are shown in Table 
II, with their ability to discriminate 
FM, expressed as percentages of cor-
rectly predicted diagnosis and AU 
ROC curves, all ≥0.70 and statistically 
significant. Plotted AU ROC curves for 
each HCP are shown in supplementary 
file Fig. S5. The Portuguese HCPs did 
not perform better or worse than the 
Dutch HCPs, although the population 
under study was from Portugal. The 
performances of rheumatologists and 
psychologists were similar.
Taken together, the eight item-sets 
elected by HCPs included 82 of the 
240 NEO-PI-R items as potentially dis-
criminating between FM and controls 
(Table III). Out of these, 37 were statis-
tically significantly different between 
the two groups and 45 were not. From 
the 152 items not selected by any of the 
HCPs, the scores of 38 of them actually 
proved to be statistically significantly 
different between FM patients and con-
trols. This distribution is different from 
chance alone (p=0.0001), indicating a 
positive association between selection 
and discriminatory property.
Table IV shows the numbers of par-
ticipants for each probability score 
for FM, and the percentages of cor-
rect classifications by the HCPs. The 
performance of the HCPs in terms of 
correctness of predicted diagnosis in-
creased with their degree of certainty, 
i.e. when the estimated probability of 
FM approached 0 (highest certainty 
the participant does not have FM) or 
10 (highest certainty the participant 
has FM). The percentages of correct 
classifications reached 75 to 100% for 
most HCPs for probabilities of 0.80 or 
higher (δ3, δ4, δ5). The HCPs only 
expressed absolute uncertainty (δ0) in 
relatively small percentages of partici-
pants (8-23%). 
The items selected by at least 3 of the 8 
HCPs as being discriminatory for FM 
are shown in Table 5, with the results of 
statistical testing. The domain neuroti-
cism is by far the most represented: 15 
neuroticism items were chosen by ≥3 
HCPs and for all these items but one, 
the scores were statistically signifi-
cantly higher in the FM group. These 
items represent 4 facets of neuroti-
cism: depression (5 items), anxiety (5 
items), angry hostility (3 items), and 
vulnerability (2 items). Other statisti-
cally significantly differentiating and 
repeatedly chosen items belong to the 
Table III. Questionnaire items classed for statistically significant differences or not 
between fibromyalgia patients and controls versus selection or not by the 8 health care 
providers (HCPs).
Testing scores of fibromyalgia Selected at least by one of the Not selected by any of the 
patients versus controls 8 HCPs                                        8 HCPs
Statistically significant different n=37: n=32: 
 1, 6, 11, 26, 36, 41, 42, 61, 64, 18, 28, 31, 32, 40, 67, 68, 81,  
 70, 71, 86, 87, 91, 115, 116, 83, 96, 103, 106, 108, 110,  
 121, 126, 136, 137, 146, 151, 113, 123, 125, 127, 128, 133,  
 167, 176, 177, 186, 187, 190, 143, 144, 145, 147, 150, 155,  
 191, 201, 211, 216, 221, 222, 156, 162, 180, 181, 232, 238 
 229, 230, 236  
  
Not statistically significant different n=45: n=126 
 10, 12, 15, 16, 21, 27, 43, 47,      all other items
 54, 55, 56, 59, 66, 79, 80, 90, 
 94, 100, 101, 104, 107, 120, 
 130, 131, 135, 140, 141, 148, 
 160, 161, 165, 171, 179, 194, 
 195, 197, 200, 204, 205, 207, 
 213, 220, 224, 225, 235
Fisher’s exact test: p=0.0001.
Table IV. Numbers of participants for each score, percentages correct classification and AU ROC curve*.
Presumed certainty HCP A HCP B HCP C HCP D HCP E HCP F HCP G HCP H
 δ5 9 (78) 4 (75) 28 (64) 24 (96)8 32 (75)2 2 (100) 0 (na) 28 (89)7
 δ4 21 (76)1 13 (85)1 26 (65) 26 (69) 45 (51) 5 (100) 19 (100)8 48 (67)1
 δ3 45 (78)5 23 (65) 55 (76)5 44 (70)2 56 (61) 28 (79)3 55 (71)3 42 (69)1
 δ2 67 (61) 63 (57) 58 (60) 54 (46) 57 (65)1 68 (59) 49 (63) 57 (51)
 δ1 76 (59) 95 (57) 67 (58) 70 (61) 45 (76)4 100 (50) 102 (61)1 52 (46)
 δ0 38 (na) 58 (na) 22 (na) 38 (na) 21 (na) 53 (na) 31 (na) 29 (na)
AU ROC (95% CI) 0.696 0.625 0.676 0.686 0.666 0.666 0.706 0.656
  (0.62-0.75) (0.55-0.69) (0.60-0.73) (0.61-0.73) (0.59-0.72) (0.60-0.72) (0.63-0.76) (0.58-0.71)
*Numbers of participants for each score as result of each health care provider scoring the 256 individuals for the probability of having fibromyalgia or not 
(0-10), here expressed as the deviation in absolute figures from score 5. Delta 0 (δ0), absolute score 5, reflects maximal uncertainty about classification; δ5, 
absolute score 10 or 0 reflects maximal presumed certainty. Between brackets, the percentages correct classification. AU ROC curve: area under the receiver 
operating characteristic curve; na: not applicable.
1p<0.05; 2p<0.01; 3p<0.005; 4p<0.001; 5p<0.0005; 6p<0.0001; 7p<0.00005; 8p<0.00001.

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facet assertiveness (1 item) and trust (1 
item), both with lower scores for FM. 
Scores on 6 of the 22 items selected by 
≥3 HCPs were not statistically signifi-
cantly different between FM and con-
trols, of which 4 items belonging to 3 
facets of the domain conscientiousness. 
Items of conscientiousness were often 
chosen by at least 1 HCP (see Supple-
mentary file Table S2), but their scores 
mostly did not differentiate between the 
FM and control group. When the results 
of Table 5 were corrected for age, 19 of 
22 items remained unchanged regard-
ing (non)significance of the difference 
between groups, but the items 1, 121 
(anxiety) and 121 (assertiveness) were 
not statistically significantly different 
anymore.
Supplementary file Table S3 shows 
agreement measures and percentage 
of agreement for the 8 HCPs, regard-
ing their choice of 20 out of 240 items. 
All but one of these measures reveal 
statistically significant rates of agree-
ment. Interpretations of the agreement 
coefficients range from poor agreement 
(1 coefficient) to almost perfect agree-
ment (2 coefficients), with 3 other co-
efficients’ ratings in between.
In supplementary file Table S4, the 
weighted chance-corrected agreement 
measures for the 8 HCPs regarding the 
estimated probability of FM for each 
of the 256 participants are presented. 
All results are statistically significant, 
with interpretations of agreement coef-
ficients ranging from slight agreement 
(3 coefficients) to moderate agreement 
(1 coefficient), with 2 coefficients with 
fair agreement in between.
Discussion
Rheumatologists and psychologists 
with experience of FM can select out of 
a full personality questionnaire a lim-
ited set of personality items that is sig-
nificantly associated with FM, with AU 
ROC curves ranging from 0.71 to 0.81. 
This performance is similar to that of 
rheumatoid factor and only moderately 
inferior to that of anti-citrullinated pro-
tein antibodies in the diagnosis of rheu-
matoid arthritis (32, 33).
There was diversity in the item sets se-
lected by the HCPs; they selected 82 dif-
ferent items as potentially discriminant 
between FM and controls. Nevertheless, 
the measures of agreement showed co-
herence underlying the apparently di-
verse choices of items. Furthermore, 
most items chosen were of the domain 
neuroticism, also indicating consistency 
between the chosen item sets.
Based on the items selected by ≥3 HCPs, 
the personality they consider associ-
ated with FM is characterised mostly by 
high levels of neuroticism, which is in 
agreement with some studies describing 
higher levels of neuroticism at the group 
level (14, 34-37). The anticipated and 
confirmed low scores on the facet trust 
indicate that besides high vulnerability, 
low resilience is considered characteris-
tic for FM. The HCPs’ expectation, in 
agreement with a previous observation 
(38), that FM would be associated with 
aspects of conscientiousness, was in 
general not confirmed, however.
HCPs’ individual participant estimates 
for the probability of FM performed 
significantly better than chance. Cor-
rectness of classification as FM patient 
or control increased with the degree 
of certainty of the estimates, reaching 
65 to 100% correct classifications for 
the higher probability scores. Thus, al-
though personality traits are not 1-to-1 
linked to individual patients with FM, 
HCPs appear able to distinguish patients 
with a FM diagnosis from controls.
This demonstrates that a relationship 
between FM and personality exists. Per-
sonality is generally considered as being 
very stable through adult life (39), and 
neuroticism has been shown to precede 
and predict joint pain even over 23 years 
(40). The other way round, there seem to 
be links between the history and inten-
sity of chronic pain, structural and func-
tional cerebral changes, and changes in 
personality (41-44). Finally, variables 
such as sensitivity of similar cerebral 
structures (e.g. the anterior cingulate 
cortex and amygdala) influence both 
proneness to psychological distress and 
sensitivity to somatic symptoms (45, 
46). Mechanisms for - probably bidirec-
tional - interactions between personal-
ity and the FM spectrum of symptoms 
are plentiful. Personality operates as a 
Table V. The NEO-PI-R items selected by at least three of the 8 health care providers are 
presented, together with their selection frequency, NEO-PI-R facet and domain, statistical 
significance level of the median difference between scores of fibromyalgia patients and 
scores of controls on that item, and direction of the difference (Dd)#.
Item Selection Facet of item Domain of item p-value Dd
number frequency 
 91 6 Anxiety Neuroticism 0.0000 +
 191 6 Depression Neuroticism 0.002 +
 6 5 Angry Hostility Neuroticism 0.0004 +
 15 5 Dutifulness Conscientiousness 0.30 NS
 26 4 Vulnerability Neuroticism 0.04 +
 86 4 Vulnerability Neuroticism 0.0001 +
 160 4 Order Conscientiousness 0.11 NS
 161 4 Depression Neuroticism 0.054 NS
 216 4 Angry Hostility Neuroticism 0.0001 +
 1 4 Anxiety Neuroticism 0.006* +
 11 3 Depression Neuroticism 0.0003 +
 41 3 Depression Neuroticism 0.004 +
 42 3 Assertiveness  Extraversion 0.046* -
 61 3 Anxiety Neuroticism 0.0001 +
 64 3 Trust Agreeableness 0.002 -
 71 3 Depression Neuroticism 0.003 +
 121 3 Anxiety Neuroticism 0.03* +
 151 3 Anxiety Neuroticism 0.0002 +
 186 3 Angry Hostility Neuroticism 0.004 +
 200 3 Achieving Striving Conscientiousness 0.12 NS
 224 3 Altruism Agreeableness 0.80 NS
 225 3 Dutifulness Conscientiousness 0.44 NS
#Direction of the difference (Dd): + statistically significantly higher score in fibromyalgia; - statisti-
cally significantly lower score in fibromyalgia; NS: no statistically significant difference.
*When corrected for age, not statistically significantly different anymore.
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modulating factor between life events 
and their psychological impact on the 
individual. Similar external realities are 
experienced differently, depending on 
one’s personality. Certain personality 
traits (e.g. high levels of neuroticism) 
make people vulnerable to stressors, 
whereas others (e.g. trust) may operate 
as resilience factors against stress. The 
experience of pain and other symptoms 
will also be modulated by personality 
factors, resulting in variable levels of 
amplifying or soothing feedback. Per-
sonality is also associated with specific 
behaviours such as avoidance of physi-
cal activity, which, in FM, have been 
associated to physical deconditioning 
and persistence of symptoms. It can-
not be ruled out, however, that person-
ality traits associated with FM are 
consequences of chronic pain and suf-
fering (41, 47, 48), or that there are bi-
directional relations between personal-
ity traits and FM manifestations. In pa-
tients with FM, subthreshold depressive 
symptom scores assessed by applying 
the Mood Spectrum-Self Report were 
higher compared to those in patients 
with RA (49). Mood disorder, FM, and 
personality characteristics such as harm 
avoidance (which is similar to neuroti-
cism) are associated: in a case-control 
study, after adjusting for depression 
and anxiety, FM patients (n=78) only 
presented decreased novelty seeking 
compared to the controls (n=78), while 
the differences in other personality traits 
such as harm avoidance were no longer 
statistically significant (50).
Our study results may have far-reaching 
implications, not only for the current 
understanding of FM, but also for re-
search in FM, as the study results stress 
the importance of continuing research 
into the psychological basis of main-
taining factors and treatment of FM. 
Previous conflicting results on a specific 
FM personality may have contributed to 
the drifting of FM research away from 
neuropsychological grounds to neuro-
physiological mechanistic investiga-
tions (51-53). This trend may be seen as 
negative in face of the promising results 
of psychotherapy (54), its potential de-
velopment in the future, and because 
psychological and neurophysiological 
mechanisms are inherently linked.
Weaknesses of the study include the 
small difference in age between the FM 
and control cohorts; however when con-
trolling for age, our main results did not 
change. HCPs were selected for their 
experience of FM; results are not neces-
sarily generalisable to all HCPs treating 
FM. Personality traits identified as asso-
ciated with FM might not be specific for 
FM, but in general associated with con-
ditions causing chronic pain and suffer-
ing. However, a recent study including 
women with FM, rheumatoid arthritis, 
spondyloarthritis or Sjögren’s syndrome 
highlighted the specificity of a FM per-
sonality (15). It cannot be excluded that 
some of our results reflect participants’ 
momentary affective states, which were 
not controlled. However, the relation-
ship between momentary affect and per-
sonality domains is strong (55), so that 
this possibility does not question the 
proof of concept provided by this study: 
that HCPs can distinguish FM patients 
on the basis of personality items.
The strengths of our study are the novel 
design, looking from another angle at 
a possible FM personality, compared 
to studies with statistical analyses of 
average scores on a questionnaire, and 
the fact that the HCPs in two different 
scientific fields were recruited from two 
countries, reducing professional and 
cultural bias.
Conclusion
HCPs can distinguish patients with FM 
from healthy controls, with a statisti-
cally significant probability, based on 
a limited set of items from a personal-
ity questionnaire. In general, the HCPs’ 
expectation that personality in FM pa-
tients is associated with higher levels 
for aspects of neuroticism (proneness 
to psychological distress) and lower 
scores for aspects of trust, proved to 
be correct. Their expectations of higher 
scores on items of conscientiousness 
were mostly not confirmed.
Key messages
•	 Health care providers can, by assess-
ing several personality scores, dis-
tinguish fibromyalgia patients from 
pain-free controls. 
•	 These discriminating personality items 
reflect mainly aspects of neuroticism.
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